Clinuvel Pharmaceuticals Limited CUV

MELBOURNE, Australia and NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026 (FY2026). The Company has declared a dividend of $0.05 per ordinary share. “CLINUVEL’s cash reserves following a decade of profitable operations give us financial independence in a period that has been challenging for many life science companies,” said

CUVL to trade on the highest tier – Global Select MarketMELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Stat

Health Canada NOC enables treatment for porphyria, metabolic disorderMELBOURNE, Australia, July 13, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC) by Health Canada for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The NOC acknowledges the compliance of the SCENESSE® new drug submission with Section C.08.002 and C.08.005 of the Canadian Food and Drug Regulations and grants CLINUVE

As Australian shares follow Wall Street into the red, with geopolitical tensions and economic uncertainties casting a shadow over market sentiment, investors are increasingly seeking refuge in more stable sectors like consumer staples. In such volatile times, growth companies with high insider ownership can offer a compelling investment narrative as they often signal strong confidence from those who know the business best.

As the Australian market anticipates a 20-point gain amid hopes for a peace deal in Iran and navigates domestic economic changes such as proposed capital gains tax reforms, investors are keenly observing how these factors might impact high-growth sectors like technology. In this environment, identifying promising tech stocks involves looking for companies that demonstrate resilience and adaptability to both international developments and local policy shifts.

As the Australian market anticipates a positive end to the week with ASX futures indicating a 0.5% rise, driven by declining oil prices and strengthening gold, investors are closely monitoring broader economic indicators and geopolitical developments such as potential peace talks involving Trump. In this context, identifying high-growth tech stocks in Australia requires careful consideration of their resilience to market volatility and ability to capitalize on emerging opportunities within...

As the Australian share market navigates a post-Budget environment marked by cautious spending and external pressures from U.S. inflation concerns, investors are keenly observing how these factors influence local indices. In such a climate, growth companies with high insider ownership may offer unique insights into potential resilience and alignment of interests between management and shareholders, making them noteworthy for those seeking stability amid broader market fluctuations.

As the Australian market navigates a soft week with the ASX200 down approximately 2%, local investors are looking to the bullish sentiment from Wall Street, which has recently set new record highs despite global geopolitical tensions. In this climate, identifying high growth tech stocks in Australia involves focusing on companies that demonstrate resilience and adaptability amidst fluctuating economic indicators and broader market sentiments.

“Totality of evidence” approach to evaluate SCENESSE®EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its “totality of evidence” approachcentral photographic review and validated disease assessment tools agreedCUV107 to compare SCENESSE® with adjunct NB-UVB vs NB-UVB monotherapyCUV107 study (n=300) to commence in 2H 2026 MELBOURNE, Australia, April 24, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that the Euro

As the Australian market navigates a complex landscape marked by geopolitical tensions and fluctuating commodity prices, investors are keeping a close eye on growth companies with high insider ownership. In such an environment, stocks with significant insider stakes can be appealing due to the potential alignment of interests between company leaders and shareholders, offering a sense of confidence amidst global uncertainties.

As Australian shares experience a mixed start to the week, diverging from Wall Street's recent rallies, investors are closely monitoring global events such as tensions in the Strait of Hormuz and fluctuations in Brent crude prices. In this dynamic environment, identifying high growth tech stocks in Australia requires a keen eye on innovation and market adaptability amidst shifting economic indicators.

The Australian market is experiencing a slight dip as investors remain cautious amid uncertainties surrounding potential fuel rationing and the impact of geopolitical tensions on global markets. In this climate, high growth tech stocks in Australia with promising potential are those that demonstrate resilience, innovation, and adaptability to navigate these complex economic conditions.

As Australian shares continue to climb amid global uncertainties, including ongoing tensions in the Middle East and concerns about fuel shortages, investors are keenly observing how these factors might impact market dynamics. In such a volatile environment, growth companies with high insider ownership often attract attention due to the confidence insiders demonstrate in their business prospects, offering potential resilience and alignment of interests with shareholders.

AAD 2026 reinforces CLINUVEL’s expertise in dermatology Step inside CLINUVEL’s Pavilion of Photomedicine and experience the energy of AAD 2026 through an exclusive video featuring behind-the-scenes of construction, expert insights from the CLINUVEL team and immersive visuals of guests engaging within the Pavilion. MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (A

As the Australian market grapples with geopolitical tensions and fluctuating indices, investors are increasingly seeking resilient opportunities amidst the uncertainty. In this environment, growth companies with high insider ownership can offer a compelling proposition, as they often demonstrate strong alignment between management and shareholder interests, potentially driving robust earnings growth even in challenging times.

As the Australian market remains steady amidst global geopolitical developments, investors are keeping a close eye on growth companies with strong insider ownership that could offer resilience in uncertain times. In such a landscape, firms where insiders hold significant stakes may align their interests closely with shareholders, potentially providing stability and confidence to investors navigating these complex conditions.

The Australian stock market is experiencing a mixed phase, with recent gains followed by profit-taking as geopolitical tensions create uncertainty. Amidst this backdrop, growth companies with high insider ownership can be attractive due to the confidence insiders demonstrate in their businesses.

As the Australian share market braces for potential geopolitical impacts, with recent developments in the Middle East influencing investor sentiment, the ASX 200 futures remain resiliently strong. In such an environment, growth companies with high insider ownership can offer a unique appeal, as they often indicate confidence from those closest to the business and can be particularly compelling amidst global uncertainties.

The Australian stock market is showing signs of resilience, with a modest rise anticipated following the Easter long weekend, buoyed by positive movements in U.S. indices and hopes for a potential ceasefire in international tensions. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between company leadership and shareholder interests.

As Australian shares edge towards a 0.5% advance, buoyed by optimism surrounding geopolitical developments in the Middle East, investors are keenly watching how these shifts might influence market dynamics across various sectors. In this evolving landscape, growth companies with high insider ownership often attract attention, as insiders' stakes can signal confidence in the company's potential and alignment with shareholder interests.